Project Grant R21NS144682
- Federal Grant Award Summary Vanderbilt University received a $614,306 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 15, 2026, with completion targeted for February 28, 2031. The award funds research into the molecular genetics of synaptic remodeling, specifically investigating the role of Neural Cell Adhesion Molecule (NCAM) and...
- Federal Grant Award Summary Vanderbilt University received a $103,449 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded December 1, 2025, with a completion date of May 31, 2027. The research project, titled "Patient-Centered Neurological Evaluation of Functional MRI Outcomes in Multiple Sclerosis," focuses on developing and...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $338,232 Project Grant award effective August 1, 2025, through September 31, 2030, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project aims to develop a novel machine learning platform that generates partially synthetic Chemical Exchange Saturation Transfer (CEST) data to...
- Federal Grant Award Summary Vanderbilt University received a $108,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Child Health and Human Development Extramural Research program (CFDA 93.865) effective July 1, 2026, through June 30, 2031. The award supports the Fundamental Neuroscience Training Program, a graduate-level predoctoral training initiative designed to develop the next generation of neuroscientists through comprehensive...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $262,500 Project Grant awarded on April 1, 2026, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The grant supports a two-year research initiative extending through March 31, 2028, located in Forest Hills, Tennessee, to develop and validate a novel predictive diagnostic...
- Federal Project Grant Award Summary Vanderbilt University received a $197,600 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 30, 2025, with completion targeted for May 31, 2027. The award funds a research initiative investigating state-dependent connectivity of impaired autonomic brain networks underlying cardiorespiratory...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1,042,170 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025 through August 31, 2033. The award supports computational neuroscience research focused on model-based analysis of brain stimulation and recording...
- Federal Project Grant Award Summary The University of Chicago received a $121,230 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025 through July 31, 2026. This award funds fundamental neuroscience research investigating terminal selector functions in motor neurons, specifically examining how transcription factors...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $545,319 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded August 15, 2025, with completion targeted for July 31, 2030. The Sahel Epilepsy Epidemiology and Genomics Study (SEEG) delivers epidemiological and genetic research services to address critical gaps in epilepsy...
- Federal Project Grant Award Summary Vanderbilt University received a $421,250 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) for a two-year project period (July 1, 2026 – June 30, 2028). The award supports research to develop state-dependent engineering of therapeutic functions in reactive astrocytes for Alzheimer's disease treatment. The project will deliver a programmable RNA-based sensing circuit that leverages endogenous ADAR (adenosine...
Vanderbilt University received a $394,915 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective July 1, 2026 through June 30, 2028. The award supports research investigating and augmenting cholinergic signaling pathways to enhance neuroprosthetic performance for paralyzed patients. The project focuses on reducing learning curves associated with brain-computer interface (BCI) systems by leveraging cholinergic neurons in the basal forebrain—a neural region known to enhance cortical plasticity during task learning. The research will explore how stimulation of cholinergic signaling, potentially through vagus nerve stimulation, can accelerate learning rates and improve accuracy in neuroprosthetic control, thereby decreasing recalibration requirements and improving outcomes for patients with spinal cord injuries, neurodegenerative diseases, and stroke. The deliverables from this research effort are expected to advance fundamental understanding of cholinergic mechanisms underlying neuroprosthetic skill acquisition and to generate data supporting therapeutic interventions that could significantly reduce BCI adaptation periods for end-users. Research findings and associated data will contribute to the NINDS mission of reducing the neurological disease burden through evidence-based improvements to brain-computer interface technology and clinical applications.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $394.9k | 6/18/26 |